TinyGemsBreaks Archive - Page 4 of 133

TuesdayAug 19, 2025 9:47 am

TinyGemsBreaks – Vision Marine Technologies Inc. (NASDAQ: VMAR) Closes $7 Million Public Offering

Vision Marine Technologies (NASDAQ: VMAR), a leader in high-voltage electric marine propulsion systems with a multi-brand boat retail and service platform, closed its public offering of 3,500,000 shares of common stock (or pre-funded warrants in lieu thereof) at $2.00 per share, raising $7,000,000 in gross proceeds before underwriting discounts and expenses. The underwriters have a 45-day option to purchase up to an additional 525,000 shares and/or pre-funded warrants. The Company plans to use the proceeds for general corporate purposes, working capital, and potential acquisitions or strategic investments in complementary businesses or technologies. To view the full press release, visit https://ibn.fm/soe0l…

MondayAug 18, 2025 12:25 pm

TinyGemsBreaks – Standard Lithium Ltd. (NYSE American: SLI) Appoints Michael Lutgring as General Counsel

Standard Lithium (NYSE American: SLI), a near-commercial lithium company, has appointed Michael Lutgring as General Counsel, effective August 18, 2025. CEO David Park welcomed Lutgring to the senior leadership team, citing his broad legal expertise as vital to supporting the Company’s continued growth and development as a public entity. To view the full press release, visit https://ibn.fm/SnlME About Standard Lithium Ltd. Standard Lithium is a leading near-commercial lithium development company focused on the sustainable development of a portfolio of large, high-grade lithium-brine properties in the United States. The Company prioritizes projects characterized by high-grade resources, robust infrastructure, skilled labor, and…

MondayAug 18, 2025 11:59 am

TinyGemsBreaks – SEGG Media Corporation (NASDAQ: SEGG, LTRYW) CEO Featured on Latest Episode of IBN’s GotStocks Podcast

SEGG Media (NASDAQ: SEGG, LTRYW), a technology leader at the nexus of sports, entertainment, and gaming, is featured in the latest episode of The GotStocks Podcast released by IBN. In the episode, SEGG President and CEO Matthew McGahan discusses the company’s growth strategy and its role in reshaping the global digital landscape, as part of IBN’s focus on spotlighting high-potential small-cap companies. To view the full press release, visit https://ibn.fm/nEjsP About SEGG Media Corporation SEGG Media (NASDAQ: SEGG, LTRYW) is a global sports, entertainment and gaming group operating a portfolio of digital assets including Sports.com, Concerts.com, and Lottery.com. Focused on…

MondayAug 18, 2025 9:00 am

TinyGemsBreaks – Vision Marine Technologies Inc. (NASDAQ: VMAR) Prices $7 Million Public Offering of Common Stock and Pre-Funded Warrants

Vision Marine Technologies (NASDAQ: VMAR), a leader in high-voltage electric marine propulsion systems and multi-brand boat retail and service, has priced a public offering of 3.5 million shares of common stock (or pre-funded warrants in lieu) at $2.00 per share, aiming to raise $7 million in gross proceeds before expenses. The Company also granted underwriters a 45-day option to purchase up to 525,000 additional shares and/or pre-funded warrants to cover over-allotments. The offering is expected to close on August 18, 2025, pending customary conditions. To view the full press release, visit https://ibn.fm/J23K5 About Vision Marine Technologies Inc. Vision Marine Technologies…

FridayAug 15, 2025 10:35 am

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Q2 2025 Results, Advances TPI 287 Toward Phase 2 GBM Trial

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company developing treatments for cancers in the brain and central nervous system, reported a Q2 2025 net loss of $2.4 million, slightly improved from $2.5 million in Q2 2024, driven by reduced Berubicin trial costs. R&D expenses rose to $1.2 million from $1.1 million on preparation for a TPI 287 trial, while G&A fell to $1.2 million from $1.4 million on lower legal, travel and stock-based compensation costs. The Company ended the quarter with $12.1 million in cash, sufficient to fund operations into the second half of 2026. CEO John Climaco said CNS is…

FridayAug 15, 2025 9:56 am

TinyGemsBreaks – Bollinger Innovations, Inc. (NASDAQ: BINI) Reports Q3 and Nine-Month 2025 Results, Provides Business Update

Bollinger Innovations (NASDAQ: BINI), an electric vehicle manufacturer, today reported financial results for the three and nine months ended June 30, 2025, and issued a business update. CEO and Chairman David Michery highlighted the July unification of the company’s commercial EV brands under the Bollinger Innovations name, reaffirming its focus on manufacturing, sales and service of commercial EV products. Michery also announced a strategic shift of Bollinger B4 manufacturing from Roush Industries in Michigan to the company’s Tunica, Mississippi, commercial manufacturing center, a move aimed at reducing costs, streamlining operations, consolidating production, and improving delivery efficiency. To view the full…

FridayAug 15, 2025 9:20 am

TinyGemsBreaks – Vision Marine Technologies Inc. (NASDAQ: VMAR) Receives Court Approval for Shareholder Claim Settlement

Vision Marine Technologies (NASDAQ: VMAR) announced that on Aug. 13, 2025, the New York State County Supreme Court, Commercial Division, formally approved the Company's settlement of an outstanding legal claim involving certain shareholders, as previously disclosed on May 16, 2025. To view the full press release, visit https://ibn.fm/bNyaW About Vision Marine Technologies Inc. Vision Marine Technologies Inc. (NASDAQ:VMAR) is a pioneer innovative marine company that offers premium boating experiences across both electric and internal combustion engine (ICE) segments. The Company designs, manufactures, and sells high-performance electric powertrain systems and boats, and operates a multi-brand boat retail and service platform through…

ThursdayAug 14, 2025 3:40 pm

TinyGemsBreaks – NextPlat Corp (NASDAQ: NXPL) Narrows Q2 Loss 66% as E-Commerce Growth Offsets Healthcare Headwinds

NextPlat (NASDAQ: NXPL, NXPLW), a global consumer products and services company in healthcare and technology, reported Q2 2025 revenue of $13.2 million versus $17.0 million a year ago, reflecting strong e-commerce growth offset by declines in healthcare operations from lower prescription volumes and reduced 340B contract revenue. Gross margin fell to 21.8% from 34.5% on mix shifts and industry drug price pressures. Operating expenses dropped to $4.7 million from $16.8 million on the absence of prior-year non-recurring charges and cost-cutting measures, producing a net loss of $1.8 million, or ($0.07) per share, compared to a $5.3 million loss last year.…

ThursdayAug 14, 2025 1:50 pm

TinyGemsBreaks – Vision Marine Technologies Inc. (NASDAQ: VMAR) Signs LOI for Exclusive Nimbus Boats Distribution on Florida’s West Coast

Vision Marine Technologies (NASDAQ: VMAR), a leader in premium on-water experiences and owner of Florida-based dealership network Nautical Ventures, announced Nautical Ventures has signed a Letter of Intent with Nimbus Boats USA to exclusively distribute Nimbus powerboats on Florida’s West Coast. The agreement, expected to be finalized by March 31, 2026, would authorize Nautical Ventures to promote, sell and service Nimbus’s Tender, Commuter, Weekender and Coupe series beginning August 1, 2025. The move aims to broaden Vision Marine’s product portfolio, strengthen its Florida presence and capture demand in the fast-growing adventure-style boat segment. Florida remains the largest U.S. market for…

ThursdayAug 14, 2025 11:00 am

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present at Webull Financial Biotech/MedTech Webinar Series

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharma company developing novel treatments for primary and metastatic cancers in the brain and central nervous system, announced it will present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech, taking place virtually Aug. 19–21, 2025. To view the full press release, visit https://ibn.fm/9OhOz About CNS Pharmaceuticals, Inc. CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system. The Company's drug candidate TPI 287 is an abeotaxane, which stabilizes microtubules and inhibits cell division, causing apoptosis…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

TinyGemsBreaks